Simplified BMI and Waist Criteria Outperform Lancet Obesity Definition

A simplified diagnostic definition combining body mass index or waist circumference criteria outperformed The Lancet obesity commission’s more complex definition in US adults, yielding higher specificity and fewer false positives when validated against DEXA body scans in a study published on August 7, 2026.

For decades, medical professionals have relied on standard metrics to assess weight-related health risks, yet traditional measures often fail to capture true body composition and metabolic danger. A detailed alternative proposed by The Lancet Diabetes & Endocrinology Commission on Clinical Obesity incorporated waist circumference alongside waist-to-height and waist-to-hip ratios. However, Medscape reported that a simpler diagnostic approach focusing just on meeting body mass index or waist circumference criteria rivals that complex definition, offering better accuracy and substantially fewer false positives.

Diagnostic Study Methodology and Comparison

Researchers evaluated these metrics using data from 1900 nonpregnant US adults aged 20 to 59 years whose whole-body dual-energy x-ray absorptiometry scan data were available from the 2017–2018 National Health and Nutrition Examination Survey. Criterion-standard obesity was defined by DEXA scans as total body fat of 25% or greater in men and 35% or greater in women, while visceral obesity required a visceral fat area of 130 square centimeters or more in men and 100 square centimeters or more in women.

Five distinct obesity definitions were tested against those DEXA standards. The analysis compared the full Lancet definition, a simplified Lancet definition omitting the waist-to-hip ratio, a definition meeting the body mass index or waist circumference criterion, waist circumference alone, and body mass index alone. Outcome measures tracked sensitivity, specificity, and the area under the receiver operating characteristic curve.

Accuracy Metrics and False Positive Rates

The full Lancet definition achieved a sensitivity of 87.7%, a specificity of 70.7%, and an area under the receiver operating characteristic curve of 0.790 for identifying DEXA-based obesity. By comparison, the simpler body mass index or waist circumference approach yielded a lower sensitivity at 74.0%, but delivered a markedly higher specificity of 89.5% and a significantly higher area under the curve of 0.818.

When projected across the US adult population aged 20 to 59 years between 2021 and 2023, the full Lancet definition would generate approximately 15.5 million false positives—classifying individuals as having obesity who do not meet the DEXA-based standard—alongside about 14.3 million false negatives. In contrast, the body mass index or waist circumference approach would yield about 5.5 million false positives and roughly 30.3 million false negatives.

Obesity Definition	Sensitivity	Specificity	Area Under Curve
Full Lancet Definition	87.7%	70.7%	0.790
Body Mass Index or Waist Circumference	74.0%	89.5%	0.818
Waist Circumference Alone	Comparable	Comparable	0.815
Body Mass Index Alone	51.3%	Not reported	0.730

Visceral Fat Performance and Clinical Recommendations

When assessing visceral obesity specifically, the full Lancet definition underperformed compared to the simpler criteria, yielding a lower specificity of 45.1% versus 65.0% and a lower area under the curve of 0.717 versus 0.785, despite achieving higher sensitivity.

Clinical Obesity as a Disease: Lancet Commission Definition & Implications for Bariatric Surgery

The study was led by Aayush Visaria, MD, MPH, from the Department of Medicine at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, and published as a research letter in JAMA Network Open.

Population Risk and Broader Health Monitoring

While diagnostic studies examine clinical thresholds, population-level health data tracks how physical measurements shift across different life stages.

Study limitations noted that the research restricted its cohort to adults aged 20 to 59 years, leaving generalizability to pediatric and older populations unaddressed. Furthermore, the analysis did not assess the Lancet definition’s distinction between preclinical and clinical obesity. Financial support for the research came from the National Institutes of Health National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities Rutgers-New York University Center for Asian Health Promotion and Excellence.